Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

Clinical trial NCT04914195 · COMPLETED

Trial details

NCT number: NCT04914195
Sponsor: Bharat Serums and Vaccines Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Prostate Adenocarcinoma

Start date: 2021-07-01
Primary completion: 2022-09-29
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.